1. Roche (53bn)
2. Pfizer (49.7bn)
3. Johnson & Johnson (42.2bn)
4. Merck (41.8bn)
5. Novartis (37.7bn)
6. AbbVie (33.3bn)
7. Takeda (31.1bn)
8. Bristol-Myers Squibb (26.1bn)
9. Sanofi (25.7bn)
10. Amgen (23.4bn)
This post was last modified on September 4, 2021 7:02 am